---
title: Gastric cancer actionable genomic alterations across diverse populations worldwide
  and pharmacogenomics strategies based on precision oncology
date: '2024-05-17'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38756376/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240517181955&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'Introduction: Gastric cancer is one of the most prevalent types of cancer
  worldwide. The World Health Organization (WHO), the International Agency for Research
  on Cancer (IARC), and the Global Cancer Statistics (GLOBOCAN) reported an age standardized
  global incidence rate of 9.2 per 100,000 individuals for gastric cancer in 2022,
  with a mortality rate of 6.1. Despite considerable progress in precision oncology
  through the efforts of international consortia, understanding the genomic features
  ...'
disable_comments: true
---
Introduction: Gastric cancer is one of the most prevalent types of cancer worldwide. The World Health Organization (WHO), the International Agency for Research on Cancer (IARC), and the Global Cancer Statistics (GLOBOCAN) reported an age standardized global incidence rate of 9.2 per 100,000 individuals for gastric cancer in 2022, with a mortality rate of 6.1. Despite considerable progress in precision oncology through the efforts of international consortia, understanding the genomic features ...